Business and Organization (Details) $ / shares in Units, $ in Thousands	1 Months Ended			6 Months Ended
	Jun. 30, 2016 USD ($) $ / shares shares	Aug. 31, 2015 USD ($) $ / shares shares	May 31, 2015 USD ($) $ / shares shares	Jun. 30, 2016 employee $ / shares
Business Acquisition [Line Items]
Number of sales employees | employee				420
Transition Therapeutics
Business Acquisition [Line Items]
Consideration transferred	$ 60,100
Bio-Reference
Business Acquisition [Line Items]
Consideration transferred		$ 950,100
Value of replacement stock options awards to holders of Bio-Reference stock options		2,259
Total purchase price		$ 950,148
EirGen
Business Acquisition [Line Items]
Consideration transferred			$ 133,800
Value of replacement stock options awards to holders of Bio-Reference stock options			33,600
Total purchase price			$ 100,200
Common Stock
Business Acquisition [Line Items]
Stock price per share (in dollars per share) | $ / shares	$ 9.34	$ 12.38	$ 13.88	$ 9.34
Common Stock | Transition Therapeutics
Business Acquisition [Line Items]
Common stock received | shares	6,400,000
Common Stock | Bio-Reference
Business Acquisition [Line Items]
Common stock received | shares		76,566,147
Acquired entity share price (in dollars per share) | $ / shares		$ 34.05
Common Stock | EirGen
Business Acquisition [Line Items]
Common stock received | shares			2,420,487